Although this chemical was first offered in 2008 in the U.K., in 2012 other retailers began to offer it. However, many research chemical retailers still do not yet have it available. Some are even having difficulties stocking it because of issues with its production. 3-MeO-PCP is also known as methoxydine or 3-Methoxyphencyclidine. It belongs to the arylcyclohexylamine family, which is a chemical pharmaceutical class and also a research chemical class. Producers of this chemical recommend that researchers start by experimenting with quantities of 10 milligrams.
3-MeO-PCP is known to work as a dissociative anesthetic. It carries effects that are sedative and also hallucinogenic along with it. Many researchers compare the dissociative characteristics to those of ketamine, although this chemical’s effects are slightly different because they don’t bind onto targets in the same way that ketamine does. So far experiments do indicate that 3-MeO-PCP is quite a bit more potent—possibly as potent as dopamine reuptake inhibitors. The chemical also works as an NMDA antagonist.